Position in NTRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$25,939,219
+$6,927,970 QoQ
Shares Held
95,558
+0.5% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#129
of 844 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026GROUPAMA ASSET MANAGMENT holds $207,911,026 across 9 Diagnostics & Research names. NTRA ranks #2 (12.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
327,868 | $164,379,900 | |
| 2 | NTRA |
Natera, Inc.
This page
|
95,558 | $25,939,219 | |
| 3 | DHR |
Danaher Corp /De/
|
53,570 | $10,204,013 | |
| 4 | QGEN |
Qiagen N.V.
|
130,000 | $5,083,000 | |
| 5 | WAT |
Waters Corp /De/
|
1,614 | $605,314 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
1,055 | $555,394 | |
| 7 | CRL |
Charles River Laboratories International, Inc.
|
2,121 | $481,021 | |
| 8 | A |
Agilent Technologies, Inc.
|
3,330 | $442,323 |
All Filings in NTRA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,939,219 | 95,558 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $19,011,249 | 95,061 | Shares | Sole | 2026-05-22 | |
| 2025-12-31 | $21,134,927 | 92,256 | Shares | Sole | 2026-02-27 | |
| 2025-09-30 | $12,424,308 | 77,184 | Shares | Sole | 2025-12-01 | |
| 2025-06-30 | $17,598,986 | 104,173 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $11,572,852 | 81,839 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $8,706,183 | 54,998 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $4,265,520 | 33,600 | Shares | Sole | 2024-11-15 | |
| No filing history on record for this holder in this stock. | ||||||